These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23621966)

  • 21. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating mental health into cardiovascular disease research in India.
    Narayanan G; Prabhakaran D
    Natl Med J India; 2012; 25(5):274-80. PubMed ID: 23448627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare Expenditure and Productivity Cost Savings from Reductions in Cardiovascular Disease and Type 2 Diabetes Associated with Increased Intake of Cereal Fibre among Australian Adults: A Cost of Illness Analysis.
    Fayet-Moore F; George A; Cassettari T; Yulin L; Tuck K; Pezzullo L
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29301298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the economic burden of diseases imputable to stress at work.
    Béjean S; Sultan-Taïeb H
    Eur J Health Econ; 2005 Mar; 6(1):16-23. PubMed ID: 15452742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An anxious heart: anxiety and the onset of cardiovascular diseases.
    Thurston RC; Rewak M; Kubzansky LD
    Prog Cardiovasc Dis; 2013; 55(6):524-37. PubMed ID: 23621962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses.
    Carlson LE; Bultz BD
    Psychooncology; 2004 Dec; 13(12):837-49; discussion 850-6. PubMed ID: 15578622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country.
    Chereches RM; Litan CM; Zlati AM; Bloom JR
    J Ment Health Policy Econ; 2012 Sep; 15(3):127-38. PubMed ID: 23001281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender effects on health care costs in cardiovascular medicine-a black box?
    Gulbins H; Vogel B; Reichenspurner H
    Thorac Cardiovasc Surg; 2013 Jan; 61(1):74-8. PubMed ID: 23225508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of comorbid depression on quality of life in adults with Type 2 diabetes.
    Egede LE; Hernández-Tejada MA
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):83-91. PubMed ID: 23402449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
    Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
    J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of rheumatoid arthritis on the burden of disease in urban China.
    Langley PC; Mu R; Wu M; Dong P; Tang B
    J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The time has come for physicians to take notice: the impact of psychosocial stressors on the heart.
    Figueredo VM
    Am J Med; 2009 Aug; 122(8):704-12. PubMed ID: 19635269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health service utilization and costs of depressive symptoms in late life - a systematic review.
    Luppa M; Sikorski C; Motzek T; Konnopka A; König HH; Riedel-Heller SG
    Curr Pharm Des; 2012; 18(36):5936-57. PubMed ID: 22681171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic burden of depression with painful symptoms.
    Greenberg PE; Leong SA; Birnbaum HG; Robinson RL
    J Clin Psychiatry; 2003; 64 Suppl 7():17-23. PubMed ID: 12755648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can post-acute care programmes for older people reduce overall costs in the health system? A case study using the Australian Transition Care Programme.
    Hall CJ; Peel NM; Comans TA; Gray LC; Scuffham PA
    Health Soc Care Community; 2012 Jan; 20(1):97-102. PubMed ID: 21848852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a chronic disease management service for patients with diabetes on hospitalisation and acute care costs.
    Rasekaba TM; Lim WK; Hutchinson AF
    Aust Health Rev; 2012 May; 36(2):205-12. PubMed ID: 22624643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.